Diagnosis of Primary Mitochondrial Diseases
Muscle & Nerve · 2025-06 · 71 (6) · 949-954
DOI: 10.1002/mus.28387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Muscle & Nerve, online erschienen am 03.04.2025. Verfasst von Salman Bhai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Mitochondrial Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Primary mitochondrial diseases are clinically heterogeneous and present diagnostic challenges due to the highly variable genotype–phenotype correlation. Clinical symptoms can range from non‐specific fatigue, exercise intolerance, and weakness to syndromic phenotypes. Though multiple testing modalities exist to identify mitochondrial diseases, most of these tests are nonspecific, or results are associated with other diseases. Molecular testing can provide an efficient path toward diagnosis, as molecular detection techniques have improved and become less costly. A “genetics first” approach can reduce diagnostic delay and improve management, where the diagnostic pathway can be an invasive or noninvasive combination of targeted or comprehensive molecular testing. Prior to ordering these tests, clinicians must consider the ambiguities and nuances of various testing modalities during the work‐up for mitochondrial diseases. Therefore, due to the diagnostic challenges associated with primary mitochondrial diseases, diagnosis should be made in the context of clinical and molecular data, potentially supplemented with histochemical and biochemical evidence. Confirmation of a diagnosis leads to improvements in the management of the disease, decreases unnecessary testing, informs reproductive planning, and improves research pipelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- H. Houston Merritt Center for Neuromuscular and Mitochondrial Disorders, Columbia Translational Neuroscience Initiative, Department of Neurology, Columbia University Medical Center, New York, New York, USA.
ORCID-Profile: Salman Bhai
Zitieren
APA
Bhai, S., & Hirano, M. (2025). Diagnosis of Primary Mitochondrial Diseases. Muscle & Nerve, 71(6), 949-954. https://doi.org/10.1002/mus.28387
Vancouver
Bhai S, Hirano M. Diagnosis of Primary Mitochondrial Diseases. Muscle & Nerve. 2025;71(6):949-954. doi:10.1002/mus.28387
BibTeX
@article{Bhai2025,
author = {Bhai, Salman and Hirano, Michio},
title = {Diagnosis of Primary Mitochondrial Diseases},
journal = {Muscle & Nerve},
year = {2025},
volume = {71},
number = {6},
pages = {949--954},
doi = {10.1002/mus.28387}
}
EUVIMED